The Calmer Co International Limited (ASX:CCO)

Market Cap	8.80M -37.3%
Revenue (ttm)	8.10M +12.5%
Net Income	-3.37M
EPS	-0.00
Shares Out	3.52B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120,000
Open	0.0020
Previous Close	0.0020
Day's Range	0.0020 - 0.0020
52-Week Range	0.0020 - 0.0050
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About ASX:CCO

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CCO

Financial Performance

In fiscal year 2025, ASX:CCO's revenue was 8.03 million, an increase of 88.48% compared to the previous year's 4.26 million. Losses were -3.99 million, 7.13% more than in 2024.